Burger King partner in Russia refuses to close 800 locations, as fast-food chain moves to divest

Burger King partner in Russia refuses to close 800 locations, as fast-food chain moves to divest


A man holds meals from the Burger King restaurant on May, 15, 2020 in Dedovsk, Russia.

Mikhail Svetlov | Getty Images

Burger King is moving to divest its 15% stake in its Russian business, but the burger chain said it can’t legally suspend operations in the market right away.

The Restaurant Brands International chain announced last week it was suspending all corporate support for its 800-plus franchised locations in Russia in response to the Kremlin’s ongoing attacks on Ukraine. The suspension includes refusing approvals for further investment or expansion and pausing operations, marketing and its supply chain.

But the company’s International President David Shear laid out in an open letter to employees on Thursday that the structure of the company’s Russian business hampers its ability to shutter restaurants in the market like some of its competitors.

“Would we like to suspend all Burger King operations immediately in Russia? Yes. Are we able to enforce a suspension of operations today? No,” Shear said.

Burger King entered Russia through a joint venture with businessperson Alexander Kolobov, Investment Capital Ukraine and VTB Capital, which has been hit by U.S. sanctions as an affiliate of a major Russian bank.

Shear said the burger chain contacted Kolobov, who is responsible for the day-to-day operations and oversight of the Russian locations, and “demanded the suspension of Burger King restaurant operations in Russia.” Kolobov refused, according to Shear.

Burger King owns a 15% stake in the joint venture, and none of the partners has a majority stake. According to Shear, Burger King can’t immediately shut down the business on its own.

“There are no legal clauses that allow us to unilaterally change the contract or allow any one of the partners to simply walk away or overturn the entire agreement,” he wrote. “No serious investor in any industry in the world would agree to a long-term business relationship with flimsy termination clauses.”

Shear said the company has started the process of divesting its stake in the joint venture, but it will take some time to unwind based on the terms of the agreement. He also said that Burger King is in full compliance with all applicable sanctions.

Enforcing Burger King’s contract would require the support of Russian authorities, which is unlikely to happen anytime soon because of the ongoing conflict and tensions with the West.



Source

Layoffs in January were the highest to start a year since 2009, Challenger says
World

Layoffs in January were the highest to start a year since 2009, Challenger says

An Amazon Go store in New York, US, on Tuesday, Jan. 27, 2026. Michael Nagle | Bloomberg | Getty Images Layoff plans hit their highest January total since the global financial crisis while hiring intentions reached their lowest since the same period, outplacement firm Challenger, Gray & Christmas reported Thursday. U.S. employers announced 108,435 layoffs […]

Read More
ECB holds rates but it’s not a ‘non-event,’ economists say. Here’s why
World

ECB holds rates but it’s not a ‘non-event,’ economists say. Here’s why

A projection of a Euro currency sign is pictured on the facade of the European Central Bank (ECB) headquarters in Frankfurt am Main, western Germany, on Dec. 30, 2025. Kirill Kudryavtsev | Afp | Getty Images The European Central Bank on Thursday kept policy rates unchanged for the fifth consecutive meeting, with its key interest […]

Read More
Novo Nordisk and Eli Lilly tumble after Hims & Hers announce  copy of Wegovy pill
World

Novo Nordisk and Eli Lilly tumble after Hims & Hers announce $49 copy of Wegovy pill

Weight-loss drugmakers Eli Lilly and Novo Nordisk tumbled after telehealth company Hims & Hers announced Thursday it will offer a copy of the newly launched Wegovy pill for $49, far less than the $149 Novo sells the branded pill for. Copenhagen-listed shares of Novo dropped as much as 9% on the news, while Eli Lilly […]

Read More